Studies on the mechanism of action of mammalian hepatic azoreductase. II. The effects of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azoreductase activities.
D000818:Animals; D001391:Azo Compounds / Q000378:metabolism; D002248:Carbon Monoxide / Q000494:pharmacology*; D003580:Cytochromes / Q000378:metabolism; D005260:Female; D008049:Lipase; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D008748:Methylcholanthrene / Q000494:pharmacology*; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology*; D009249:NADP; D009929:Organ Size; D010088:Oxidoreductases / Q000378:metabolism*; D010634:Phenobarbital / Q000494:pharmacology*; D051381:Rats; D013778:Tetrazolium Salts / Q000378:metabolism
D001391:Azo Compounds; D003580:Cytochromes; D013778:Tetrazolium Salts; D009249:NADP; D008748:Methylcholanthrene; D002248:Carbon Monoxide; D010088:Oxidoreductases; D008049:Lipase; D010634:Phenobarbital